Stryker Corporation
Stryker operates as a medical technology company with two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics segment provides implants for joint replacements and spinal surgeries. The MedSurg and Neurotechnology segment offers surgical equipment, navigation systems, and medical devices for various specialties. The company sells products to doctors, hospitals, and healthcare facilities through subsidiaries, branches, dealers, and distributors in 75 countries.
Overview
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): an asset-light, cash-generative model, high, stable gross margins (pricing power) and operating margins that held up every year.
- Pricing power: gross margin has held between 63% and 64% over the last 6 years (latest 64.0%).
- Asset-light, cash-generative model: capital expenditure takes only 3.1% of revenue and free cash flow was positive in each of the last 6 years.
- Predictable earnings: earnings per share have grown along a steady trend of 15.1% a year.
- Consistent growth: revenue has compounded at 11.8% a year over 5 years, rising every year.
- Scale advantage: ranks #3 by enterprise value ($140 billion) among the 53 Medical Devices companies we cover.
Weaknesses
- Our discounted cash flow target price (179.60 USD) is 46% below the current price.
Key Financial Data